Bionano Genomics

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$6,733
$6,457
$8,163
$6,073
Gross Profit
3,477
2,938
3,417
-8,446
EBITDA
-4,343
-8,465
-17,648
-38,474
EBIT
-6,774
-10,950
-20,097
-44,154
Net Income
-6,857
-3,102
-20,125
-44,246
Net Change In Cash
6,733
6,457
8,163
6,073
Free Cash Flow
-3,487
-2,764
-6,504
-13,309
Cash
3,562
3,625
9,173
8,794
Basic Shares
3,441
2,694
1,902
1,459

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$30,776
$36,116
$27,802
$17,981
Gross Profit
380
9,566
5,945
3,874
EBITDA
-97,469
-213,604
-120,315
-73,855
EBIT
-111,695
-227,312
-130,414
-77,826
Net Income
-112,017
-232,493
-132,596
-72,435
Net Change In Cash
30,776
36,116
27,802
17,981
Cost of Revenue
-19,042
-13,878
Free Cash Flow
-69,025
-126,872
-128,118
-73,387
Cash
9,173
17,948
5,091
24,571
Basic Shares
1,902
580
491
470

Earnings Calls

Quarter EPS
2025-06-30
-$1.99
2025-03-31
-$10.78
2024-12-31
-$7.73
2024-09-30
-$0.26